Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Pilot Study of Ketoconazole in Metastatic Hormone-Refractory Prostate Cancer
2008-000080-42Phase 2Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ketoconazole in prostate cancer (PCa), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: Biochemical response by PSA. Started Apr 2009; status: completed.
02
Drugs
ketoconazole
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2008-000080-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000080-42.